Analystreport

Recro Pharma Inc (NASDAQ: REPH) had its price target raised by analysts at Stephens from $17.00 to $23.00.

Recro Pharma, Inc.  (REPH) 
Last recro pharma, inc. earnings: 11/8 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.recropharma.com